Report ID: SQMIG35B2341
Report ID: SQMIG35B2341
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35B2341 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
117
|Figures:
77
Global Surgical Glue Market size was valued at USD 3.28 Billion in 2024 and is poised to grow from USD 3.5 Billion in 2025 to USD 5.94 Billion by 2033, growing at a CAGR of 6.83% during the forecast period (2026-2033).
The surgical glue market comprises adhesives and sealants used to close skin and internal tissues, and it matters because these products shorten operating time, reduce infection rates, and improve wound aesthetics and function. The primary driver is the shift toward minimally invasive and outpatient procedures that require fast, reliable closure without extensive suturing, pushing surgeons to adopt topical cyanoacrylates and advanced fibrin or synthetic sealants. Historically the market progressed from early medical cyanoacrylates to commercial brands such as Dermabond and fibrin products like Tisseel, and recent development focuses on bioresorbable internal adhesives to meet complex surgical needs and regulatory acceptance.A key growth factor is ongoing material and formulation innovation that transforms clinical applicability, so when researchers develop stronger, flexible and bioresorbable adhesives surgeons can replace sutures for many procedures and that drives broader adoption and higher market revenues. For example stronger synthetic sealants enable laparoscopic anastomoses and faster skin closure in emergency departments, which decreases procedure time, lowers infection rates and shortens hospital stays, producing demonstrable cost savings that encourage hospital procurement. In parallel expanding healthcare access in Asia-Pacific and rising elderly populations increase surgical volumes, creating opportunities for product differentiation, combination hemostatic-adhesives and targeted reimbursement strategies and adoption.
How is AI optimizing surgical glue formulation and application?
AI is optimizing surgical glue through smarter formulation and application. For formulation AI analyzes material databases and predicts how polymer blends, crosslinkers and biocompatible additives interact, enabling virtual screening and digital twin testing that reduce physical trial needs. For application AI guides delivery by combining imaging and robotic control to ensure precise placement and consistent curing which improves reliability and lowers tissue trauma. Market demand for faster regulatory paths and improved outcomes is driving adoption. Real world examples include FDA cleared high viscosity tissue adhesives from Resivant Medical which illustrate renewed product innovation. Proximie shows AI being embedded in operating rooms to support procedural intelligence.Henkel April 2026, launched an AI powered platform called Loctite Solve that creates digital twins of adhesive formulations and simulates performance. This capability accelerates translation of lab formulations toward sterile biocompatible surgical adhesives and helps manufacturers iterate safer more effective glues and shortens development timelines.
Market snapshot - (2026-2033)
Global Market Size
USD 3.28 Billion
Largest Segment
Synthetic Surgical Glues
Fastest Growth
Natural Biological Glues
Growth Rate
6.83% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global surgical glue market is segmented by product chemistry composition, application clinical area, end-user, distribution channel and region. Based on product chemistry composition, the market is segmented into Synthetic Surgical Glues and Natural Biological Glues. Based on application clinical area, the market is segmented into General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Ophthalmic Surgery, Central Nervous System Surgery and Others. Based on end-user, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Centers. Based on distribution channel, the market is segmented into Direct and Indirect. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Synthetic Surgical Glues segment dominates because clinicians favor their predictable polymer chemistry, rapid and controllable curing, and robust mechanical strength, which reliably achieve hemostasis and tissue approximation across diverse procedures. Manufacturing scalability and longer shelf life reduce logistical barriers while consistent regulatory pathways and extensive clinical data foster hospital formulary adoption. These factors drive procurement preference, support supplier investment in formulation improvements, and entrench synthetic adhesives in standard surgical workflows.
However, Natural Biological Glues are emerging as the key high-growth area due to increasing demand for biologically compatible sealants in delicate and contaminated wounds, improvements in recombinant production reducing variability, and clinical enthusiasm for tissue-regenerative properties. This uptake opens new indications, encourages tailored formulations, and creates premium opportunities across surgical specialties.
Cardiovascular Surgery segment dominates because vascular procedures present acute hemostatic and sealing challenges where reliable adhesives can reduce bleeding, shorten operative time, and lower reoperation risk, making glue choice critical. High clinical value and payer recognition for improved outcomes drive hospital procurement and specialized product development. Consequently, manufacturers prioritize cardiovascular indications, invest in targeted formulations and training, and secure clinical evidence that reinforces adoption in complex cardiac and vascular interventions.
However, Ophthalmic Surgery is witnessing the strongest growth momentum as surgeons seek atraumatic, microscale adhesives for corneal and intraocular procedures, and advances in biocompatible, clear formulations enable new minimally invasive techniques. Regulatory approvals for ocular indications and increasing patient demand for faster recovery are accelerating adoption and expanding niche product pipelines.
To get detailed segments analysis, Request a Free Sample Report
North America dominates the global surgical glue market due to a convergence of mature healthcare infrastructure, robust clinical research ecosystems, and concentrated industry presence. High levels of public and private investment in medical technologies support rapid adoption of advanced adhesive systems across acute care and outpatient settings. Well-established regulatory and reimbursement pathways facilitate commercialization, while dense networks of leading hospitals and specialist clinicians generate clinical evidence and best practices. Local manufacturing capabilities and strategic partnerships between suppliers and healthcare providers ensure reliable supply chains and tailored product portfolios. Strong academic-industry collaboration also underpins continual product refinement and clinician acceptance.
Surgical Glue Market United States emphasizes early clinical adoption supported by comprehensive surgical infrastructure, high research activity, and extensive specialty networks. Strong regulatory pathways and collaborative relationships between suppliers and leading hospitals generate rigorous clinical evidence and facilitate market access. Reimbursement mechanisms and private sector investment encourage innovation and widespread availability across acute and ambulatory care settings, while supply chain resilience through strategic partnerships sustains clinician engagement and product refinement.
Surgical Glue Market Canada is characterized by a publicly funded healthcare system with centralized procurement processes and emphasis on evidence-based adoption. Regional health authorities and tertiary hospitals drive clinical evaluations and integration of adhesive technologies for diverse surgical procedures. Health technology assessments and negotiated purchasing foster cost-effective utilization while collaborations between suppliers and academic centers support local training initiatives and measured market expansion that balances safety, quality and sustainability.
The rapid expansion in Europe is driven by growing clinical emphasis on minimally invasive and tissue-preserving techniques, supported by well-established hospital systems and coordinated procurement frameworks. Regional centers of medical device innovation and manufacturing provide a strong base for product development and commercialization, while regulatory harmonization and reimbursement mechanisms in many jurisdictions facilitate market entry. Cross-border collaboration among clinicians and academic institutions generates comparative clinical evidence and practice guidelines that encourage adoption. Public and private investment in surgical capability upgrades, coupled with increasing surgeon familiarity and training programs, accelerates penetration across both established and emerging markets. Strategic partnerships between multinational suppliers and local distributors ensure tailored product offerings and supply continuity, reinforcing the continent as a significant and diversified market.
Surgical Glue Market Germany is anchored by a robust manufacturing ecosystem and high-quality clinical infrastructure. Leading medical technology clusters and collaborations between industry and academic centers support product innovation and clinical evaluation. Decentralized procurement allows regional hospitals to trial and adopt adhesive solutions across a range of surgical specialties. Strong clinician engagement and established supply networks ensure consistent availability and sustained integration into surgical practice while maintaining rigorous quality standards.
Surgical Glue Market United Kingdom has emerged as a rapidly expanding opportunity driven by centralized procurement, innovation hubs, and active clinical adoption. Pilot programs within public health systems and collaborative initiatives between industry and research institutions accelerate evaluation and scaling of adhesive technologies. Regulatory adaptability and focused training programs encourage wider surgeon acceptance. Dynamic distribution partnerships and a favorable ecosystem for medical innovation support broad market penetration while sustaining quality.
Surgical Glue Market France shows emerging momentum supported by strong clinical networks and regional centers of surgical excellence. Health authorities and hospital systems emphasize evidence-based evaluation and careful integration of adhesive solutions to complement established surgical protocols. Collaboration between manufacturers and academic institutions fosters local research and clinician training. Centralized reimbursement assessments and negotiated procurement approaches encourage measured adoption while maintaining patient safety and cost effectiveness priorities for broader uptake.
Asia Pacific is strengthening its position through a combination of expanding healthcare infrastructure, growing clinical capacity, and increasing local production capabilities. Governments and private investors are upgrading surgical facilities and promoting technology transfer, enabling wider access to adhesive technologies across diverse care settings. Strategic collaborations between global suppliers and regional manufacturers accelerate product localization and regulatory alignment, while targeted training and demonstration programs build clinician confidence. Advanced markets in the region contribute high-quality research and innovation, complementing rapid adoption in emerging markets driven by medical tourism and cost-conscious procurement. Policy reforms improving regulatory efficiency and harmonized standards further reduce barriers to market entry, enabling sustained regional integration.
Surgical Glue Market Japan is characterized by high-quality regulatory standards and strong investment in clinical research. Domestic manufacturers and research institutions collaborate closely with hospitals to refine adhesive technologies for specialized surgical applications. Emphasis on rigorous evaluation and clinician training ensures integration into complex surgical workflows. Established supply chains and partnerships with global suppliers support product availability, while focused innovation delivers solutions aligned with local clinical preferences and quality expectations.
Surgical Glue Market South Korea benefits from a dynamic medical innovation ecosystem combining advanced hospital networks with agile manufacturing capabilities. Collaborative partnerships between local firms and international suppliers accelerate technology transfer and product localization, while focused clinical training programs increase surgeon familiarity with adhesive solutions. Efficient distribution channels and supportive regulatory pathways facilitate access. Emphasis on quality, innovation and exports positions the market as a regional hub for surgical adhesives.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Preference For Minimally Invasive Surgery
Advances In Bioadhesive Formulations
Stringent Regulatory Approval Requirements
High Cost Of Specialty Adhesives
Request Free Customization of this report to help us to meet your business objectives.
I can do that, but I need to verify recent company founding dates and developments to ensure both startups meet your rule (not established before 2019) and are real. Do you want me to look these up and use verified, up-to-date sources before I generate the two startup bullets?
Top Player’s Company Profile
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. As per SkyQuest analysis, the global surgical glue market is driven primarily by the shift toward minimally invasive and outpatient procedures that demand faster, reliable tissue closure and is further propelled by advances in bioadhesive formulations that improve biocompatibility, strength and degradability. However, stringent and variable regulatory approval requirements remain a key restraint, lengthening time to market and increasing development costs. North America continues to dominate the market thanks to mature healthcare infrastructure, robust clinical research and favorable reimbursement pathways, while synthetic surgical glues are the leading segment because of predictable polymer chemistry, rapid curing, strong clinical evidence and supply chain scalability, positioning suppliers to capitalize on growing procedural adoption.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 3.28 Billion |
| Market size value in 2033 | USD 5.94 Billion |
| Growth Rate | 6.83% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Surgical Glue Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Surgical Glue Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Surgical Glue Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Surgical Glue Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients